TIME Selects TrialJectory’s AI-Powered, Clinical Trial-Matching Platform for ‘100 Best Inventions of 2020’ List

NEW YORK, Nov. 20, 2020 /PRNewswire/ — TrialJectory (“the Company”), an AI-powered digital well being platform that empowers most cancers sufferers to search out superior new remedy choices that match their exact profiles, introduced at present that TIME has chosen the Company’s patient-first, scientific trial-matching platform for its “100 Best Inventions of 2020” annual checklist.

“Millions of Americans are currently suffering from cancer while also facing major difficulties navigating the complex, jargon-y world of clinical trials. This is unacceptable since these trials often provide better alternatives and result in better outcomes than the standard of care,” mentioned Tzvia Bader, CEO and co-founder, TrialJectory. “AI is the key to democratizing cancer care for all patients – no matter where they are located or their socioeconomic status – and this is at the heart of TrialJectory’s work. Through technology, for the first time ever, patients now have a clear voice and say in their treatment journey, allowing them to effectively partner with their oncologists to determine the best plan for their individual diagnoses.”

Completely free for most cancers sufferers, TrialJectory’s platform mimics the thoughts of an oncologist to find all out there scientific trial info in a approach {that a} single physician doesn’t have the time or means to do on his or her personal. In addition to trial-matching, TrialJectory’s Treatment Finder software is the world’s first know-how that permits most cancers sufferers throughout the U.S. to view real-world remedy information from different sufferers who’ve the identical medical profile – i.e., the identical most cancers kind, the identical stage, the identical genetic mutations and biomarkers – together with the remedy’s consequence / remission fee, whether or not sufferers skilled illness development or toxicity and far more.

TrialJectory SaaS intelligence platform, Patient Match Optimizer, permits pharmaceutical corporations for the primary time ever to establish affected person boundaries of their journey to taking part in scientific trials. From operational to design boundaries, the platform uncovers elements that go right into a affected person’s early decision-making course of throughout scientific trial pre-screening, which might instantly influence trial recruitment and retention, and makes use of real-time real-world affected person information to establish gaps inside the trial design. By giving Big Pharma and CROs visibility into the info and predicting areas for optimization, the platform permits Pharma to shorten the enrollment interval, scale back prices, and expedite time to market, in the end bringing lifesaving medicine to the market sooner for sufferers in want.

To assemble the “100 Best Innovations of 2020” checklist, TIME editors and correspondents around the globe solicited nominations, which had been then evaluated on key elements that included originality, creativity, effectiveness, ambition and influence.

About TrialJectory

TrialJectory is a patient-first digital well being firm with a mission to democratize entry to superior most cancers remedy. Recognized by TIME as considered one of “The 100 Best Inventions of 2020,” TrialJectory makes use of synthetic intelligence (AI) to empower sufferers to personal their most cancers journey and analyzes its world affected person neighborhood’s real-world information to empower most cancers sufferers to take advantage of knowledgeable choices about their care. For extra info, please go to www.trialjectory.com, and observe the Company on Facebook, LinkedIn and Twitter.

SOURCE TrialJectory

LEAVE A REPLY

Please enter your comment!
Please enter your name here